Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Registry Following Stenting for Stroke Caused by Narrowed Brain Arteries

Collects data on adults who receive brain artery stents after stroke from narrowing.

Plain-language title generated from the registry record
Registry title: Stenting for Ischemic Strokes Secondary to Medically Refractory Intracranial Atherosclerotic Disease

Key facts

Where
Memphis, United StatesSee the site

Where in United States

  • Semmes Murphey ClinicMemphis, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Nitin Goyal
Trial code
NCT06790147
Record updated
16 May 2025
Original description
The goal of this observational study is to establish a prospective multicenter registry of patients undergoing intracranial stenting for ischemic strokes caused by medically refractory ICAD. The study aims to evaluate current practice patterns, periprocedural outcomes, and delayed outcomes.Read full original descriptionShow less

Stenting for Ischemic Strokes Secondary to Medically Refractory Intracranial Atherosclerotic Disease: STRICT-ICAS

The goal of this observational study is to establish a prospective multicenter registry of patients undergoing intracranial stenting for ischemic strokes caused by medically refractory ICAD. The study aims to evaluate current practice patterns, periprocedural outcomes, and delayed outcomes.

Researchers will collect demographic and procedural data from patients who undergo intracranial stenting after having an ischemic stroke caused by medically refractory ICAD.

Inclusion: Adult patients with ICAD resulting in 70-99% vessel stenosis who undergo PTAS with any device; Patients will have to experience a stroke despite medical management involving risk factor modification and an antiplatelet agent; Baseline modified Rankin Scale (mRS) ≤ 3; Performance of the endovascular procedure at least 3 days after the last stroke.

Exclusion: Performance of the endovascular procedure less than 3 days after the last stroke; Patients undergoing intracranial stenting for first stroke caused by ICAD; Large vessel occlusion strokes undergoing rescue intracranial stenting will not be included; Baseline modified Rankin Scale (mRS) >3; Adult patients with ICAD resulting in <70% vessel stenosis.

ClinicalTrials.gov NCT06790147